Skip to Content

ResMed, Inc. (NYSE: RMD)

Securities Class Action

  • Date:
  • 2/13/2020
  • Company Name:
  • ResMed, Inc.
  • Stock Symbol:
  • RMD
  • Status:
  • Investigating

Case Finder

Locate any case using the tools below.

NEW YORK, February 13, 2020 –  Bragar Eagel & Squire, P.C., a nationally recognized shareholder law firm, is investigating potential claims against certain officers and directors of ResMed, Inc. (NYSE: RMD) on behalf of long-term stockholders.

Our investigation follows news that ResMed will pay $37.5 million to settle federal claims that free services, loan guarantees and other incentives it offered to customers amounted to unlawful kickbacks to induce sales of its sleep apnea machines.

The U.S Justice Department announced the civil settlement Wednesday, January 15, 2020, which ends probes that stemmed from whistleblower complaints starting in 2016.

If you are a long-term stockholder of ResMed securities, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact  Melissa Fortunato or Marion Passmore by email at investigations@bespc.com, telephone at (646) 860-9156, or by filling out the contact form below. There is no cost or obligation to you.
The individual or institution below (“Plaintiff”) has reviewed and agrees to the Bragar Eagel & Squire, P.C. (“BESPC”) retainer agreement and authorizes BESPC to prosecute an action on Plaintiff’s behalf under the federal securities laws or applicable state laws to recover damages on behalf of investors in ResMed. BESPC will prosecute the action on a full contingency basis and will forward all costs and expenses.
 

Case Finder

Locate any case using the tools below.

You may share a link to this page on any of the sites listed below or send link via email: